GlassScriptPhysician profile
Bincy Samuel
NPI 1376054775
$2,169.73
in general payments reported to CMS, 2019-2025
20 companies · $581 in 2025
The $581 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $88.33 · 2022: $777 · 2023: $163 · 2024: $561 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,304.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $483.60 | 2022 | |
| Eisai INC. | $348.42 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $334.46 | 2023-2025 | Rexulti |
| Neurocrine Biosciences, INC. | $186.31 | 2022-2024 | Ingrezza, Ongentys |
| Lilly USA, LLC | $181.78 | 2024-2025 | Amyvid, Kisunla |
| Biogen, INC. | $136.34 | 2021-2025 | Leqembi |
| Mylan Specialty L.P. | $128.74 | 2022-2023 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $59.88 | 2022-2024 | Austedo Xr |
| Glaxosmithkline, LLC. | $51.98 | 2024-2025 | Shingrix |
| Avanir Pharmaceuticals, INC. | $38.85 | 2022 | |
| Sumitomo Pharma America, INC. | $33.34 | 2025 | Gemtesa |
| Lundbeck LLC | $31.83 | 2025 | Rexulti |
| Acadia Pharmaceuticals INC | $30.63 | 2022-2024 | Nuplazid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.71 | 2022-2023 | Ofev |
| Life Molecular Imaging LTD | $23.93 | 2025 | Neuraceq |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $18.11 | 2024 | |
| Dexcom, INC. | $14.27 | 2024 | Dexcom G6 Transmitter |
| Ultragenyx Pharmaceutical INC. | $13.62 | 2024 | Crysvita |
| Exact Sciences Corporation | $13.53 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bincy Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.